{"id":"iv-doxapram","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"8%","effect":"Vomiting"},{"rate":"6%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Doxapram works by stimulating the central nervous system to increase respiratory rate, which can be beneficial in patients with respiratory depression.","oneSentence":"Stimulates the central nervous system to increase respiratory rate","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:02:48.760Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory depression"}]},"trialDetails":[{"nctId":"NCT04430790","phase":"PHASE3","title":"Doxapram Therapy in Preterm Infants (DOXA Trial)","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2020-06-15","conditions":"Apnea of Prematurity, Respiratory Insufficiency","enrollment":396},{"nctId":"NCT00477451","phase":"PHASE2","title":"Staccato Alprazolam in Panic Attack","status":"COMPLETED","sponsor":"Alexza Pharmaceuticals, Inc.","startDate":"2007-05","conditions":"Treatment of Induced Panic Attack","enrollment":49},{"nctId":"NCT02820025","phase":"NA","title":"The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence","status":"UNKNOWN","sponsor":"General Hospital of Ningxia Medical University","startDate":"2015-10","conditions":"Anesthesia","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"IV doxapram","genericName":"IV doxapram","companyName":"Alexza Pharmaceuticals, Inc.","companyId":"alexza-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Stimulates the central nervous system to increase respiratory rate Used for Respiratory depression.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}